Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ionis Pharmaceuticals (IONS)
NASDAQ:IONS
RESEARCH TOOLSreports
Ionis Pharmaceuticals (IONS) Stock Price & Analysis
1,199 Followers
IONS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$32.69 - $50.39
Previous Close$49.7
Volume835.35K
Average Volume (3M)1.06M
Market Cap
$7.15B
Enterprise Value$5.09B
Total Cash (Recent Filing)$2.24B
Total Debt (Recent Filing)$173.04M
Price to Earnings (P/E)-17.4
Beta0.69
Next Earnings
Feb 22, 2024EPS Estimate
-$0.9Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.86
Shares Outstanding143,472,119
10 Day Avg. Volume886,600
30 Day Avg. Volume1,063,252
Standard Deviation0.09
R-Squared0.07
Alpha-0.00161
Financial Highlights & Ratios
Price to Book (P/B)22.66
Price to Sales (P/S)8.80
Price to Cash Flow (P/CF)-16.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue9.47
Enterprise Value/Gross Profit8.87
Enterprise Value/Ebitda-15.05
Forecast
1Y Price Target
$53.00Price Target Upside9.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
Ionis Pharmaceuticals News
Press ReleasesIonis reports third quarter 2023 financial results
Ownership Overview
0.95% Insiders
36.58% Mutual Funds
54.69% Other Institutional Investors
7.77% Public Companies and
Individual Investors
IONS FAQ
What was Ionis Pharmaceuticals’s price range in the past 12 months?
Ionis Pharmaceuticals lowest stock price was $32.69 and its highest was $50.39 in the past 12 months.
What is Ionis Pharmaceuticals’s market cap?
Currently, no data Available
When is Ionis Pharmaceuticals’s upcoming earnings report date?
Ionis Pharmaceuticals’s upcoming earnings report date is Feb 22, 2024 which is in 86 days.
How were Ionis Pharmaceuticals’s earnings last quarter?
Ionis Pharmaceuticals released its earnings results on Nov 02, 2023. The company reported -$1.03 earnings per share for the quarter, missing the consensus estimate of -$1.008 by -$0.022.
Is Ionis Pharmaceuticals overvalued?
According to Wall Street analysts Ionis Pharmaceuticals’s price is currently Undervalued.
Does Ionis Pharmaceuticals pay dividends?
Ionis Pharmaceuticals does not currently pay dividends.
What is Ionis Pharmaceuticals’s EPS estimate?
Ionis Pharmaceuticals’s EPS estimate is -$0.9.
How many shares outstanding does Ionis Pharmaceuticals have?
Ionis Pharmaceuticals has 143,472,120 shares outstanding.
What happened to Ionis Pharmaceuticals’s price movement after its last earnings report?
Ionis Pharmaceuticals reported an EPS of -$1.03 in its last earnings report, missing expectations of -$1.008. Following the earnings report the stock price went down -3.38%.
Which hedge fund is a major shareholder of Ionis Pharmaceuticals?
Among the largest hedge funds holding Ionis Pharmaceuticals’s share is Tweedy Browne CO LLC. It holds Ionis Pharmaceuticals’s shares valued at 159M.
---
Ionis Pharmaceuticals Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$53.00 (9.64% Upside)
$53.00 (9.64% Upside)
Blogger Sentiment
Neutral
IONS Sentiment 60%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 77.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.8%
Last 30 Days ▼ 3.8%
Last 30 Days ▼ 3.8%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.58%
12-Months-Change
Fundamentals
Return on Equity
-89.91%
Trailing 12-Months
Asset Growth
21.14%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ionis Pharmaceuticals
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.
---
Top 5 ETFs holding IONS
Vanguard Total Stock Market ETF
$188.84M
Vanguard Health Care ETF
$19.51M
Vanguard Russell 1000 Growth ETF
$4.56M
Vanguard Russell 1000 ETF
$896.20K
Vanguard Russell 3000 ETF
$412.60K
Up to five ETFs with an Outperform Smart Score that hold IONS. The ETFs are listed according to market value of IONS within the ETF
---